Crescent Biopharma, Inc.
GYRENASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $644.08M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $5.44$9.42
- Volume (live)
- -
- Avg. volume (3M)
- 174.65K
Crescent Biopharma (GYRE) Stock Price & Financial Analysis
Crescent Biopharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $6.04 - $6.43 |
|---|---|
| 52-Week High | $9.42 |
| 52-Week Low | $5.44 |
| Open | $6.41 |
| Volume (last close) | 142.87K |
| Average Volume (3M) | 174.65K |
| Revenue (TTM) | 119.38M |
|---|---|
| Net Income (TTM) | -17.33M |
| Free Cash Flow (TTM) | -15.76M |
| EPS (TTM) | −$0.18 |
| Profit Margin | -14.52% |
| Operating Margin | -13.54% |
| Return on Equity (ROE) | -16.06% |
| Debt to Equity | 0.03 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Last Dividend Ex-Date | Jan 13, 2023 |
| Market Cap | 644.08M |
|---|---|
| Shares Outstanding | 100.64M |
| Price to Sales (P/S) | 5.40 |
| Price to Book (P/B) | 5.97 |
| EV/EBITDA | -46.76 |
| 50-Day MA | $6.88 |
|---|---|
| 200-Day MA | $7.06 |
| 1-Year Change | −22.89% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Crescent Biopharma at a Glance
As of the Oct 16, 2026 close, Crescent Biopharma (GYRE) has a market capitalization of $644.08M. The stock trades at 5.4× sales. Over the trailing twelve months it lost $17.33M on revenue of $119.38M and burned $15.76M of free cash flow. Revenue grew 15.3% year over year.
As of its latest reported balance sheet, it holds $43.29M in cash and securities against $3.42M of debt, a net cash position of $39.87M.
Crescent Biopharma does not currently pay a dividend.
The share price is down 22.9% over the past year. At $6.08 (the Oct 16, 2026 close) it sits within its 52-week range of $5.44 to $9.42, below its 200-day moving average of $7.06.
Frequently Asked Questions About Crescent Biopharma
What is the current stock price for GYRE?
As of the Oct 16, 2026 close, GYRE stock trades at $6.08. The 52-week range is $5.44–$9.42, with a day range of $6.04–$6.43.
What is the P/E ratio for GYRE?
The P/E ratio (Price-to-Earnings) for GYRE is shown in the Key Statistics section. This valuation metric helps compare Crescent Biopharma, Inc. to industry peers.
Does GYRE pay dividends?
Crescent Biopharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for GYRE?
Analyst ratings and recommendations for GYRE are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of GYRE?
As of the Oct 16, 2026 close, Crescent Biopharma's market capitalization is $611.9M, classifying it as a small-cap company. Crescent Biopharma operates in the Healthcare sector within the Biotechnology industry.